Collaborative innovation in drug discovery : (Record no. 20809)

MARC details
000 -LEADER
fixed length control field 05799cam a2200817 i 4500
001 - CONTROL NUMBER
control field ocn857664391
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20230823095259.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |||||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 130903s2014 nju ob 001 0 eng
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2013035811
040 ## - CATALOGING SOURCE
Original cataloging agency DLC
Language of cataloging eng
Description conventions rda
Transcribing agency DLC
Modifying agency YDX
-- EBLCP
-- N$T
-- IDEBK
-- DG1
-- YDXCP
-- E7B
-- CUI
-- CUS
-- CDX
-- COO
-- RECBK
-- OCLCF
-- STF
-- OCLCQ
-- DEBBG
-- LOA
019 ## -
-- 905856541
-- 929527164
-- 960199933
-- 961650872
-- 962632779
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781118778128 (ePub)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 111877812X (ePub)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781118778159 (Adobe PDF)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1118778154 (Adobe PDF)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9780470917374 (cloth)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781118778166
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1118778162
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 0470917377
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9780470917374
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781306571784
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1306571782
029 1# - (OCLC)
OCLC library identifier CHVBK
System control number 325941823
029 1# - (OCLC)
OCLC library identifier CHBIS
System control number 010259524
029 1# - (OCLC)
OCLC library identifier NZ1
System control number 15922666
029 1# - (OCLC)
OCLC library identifier NZ1
System control number 16097921
029 1# - (OCLC)
OCLC library identifier DEBBG
System control number BV042792988
029 1# - (OCLC)
OCLC library identifier DEBBG
System control number BV043396198
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)857664391
Canceled/invalid control number (OCoLC)905856541
-- (OCoLC)929527164
-- (OCoLC)960199933
-- (OCoLC)961650872
-- (OCoLC)962632779
042 ## - AUTHENTICATION CODE
Authentication code pcc
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM301.25
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 745
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 071000
Source bisacsh
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.1/9
Edition number 23
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Collaborative innovation in drug discovery :
Remainder of title strategies for public and private partnerships /
Statement of responsibility, etc edited by Dr. Rathnam Chaguturu.
264 #1 -
-- Hoboken, New Jersey :
-- John Wiley & Sons Inc.,
-- [2014]
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource.
336 ## -
-- text
-- rdacontent
337 ## -
-- computer
-- rdamedia
338 ## -
-- online resource
-- rdacarrier
490 1# - SERIES STATEMENT
Series statement Wiley series on technologies for the pharmaceutical industry
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
588 ## -
-- Description based on print version record and CIP data provided by publisher.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Table of Contents; Wiley Series on Technologies for the Pharmaceutical Industry; Title page; Copyright page; Dedication; Collaborative Drug Discovery Ethos; Foreword; Preface; About the Book; About the Editor; Contributors; Part I: Perspectives on Collaborative Innovation; 1: Productive Relationships in Research and Development between Government, Industry, and Universities; Universities, Government, and Industry: Historical Beginnings in Prussia; Refinement and Broad Adoption: the United States; General Principles for Success; Notes; 2: Divided We Fall; Challenges; Collaboration Models
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Examples of Successful Biomedical CollaborationsPrinciples of Collaboration; Governance, Administration, and Autonomy; Human Factors; Conclusion; References; 3: Innovation: Open Source and Nonprofit Models in Drug Discovery; Why Do People Innovate?; How Do We Encourage Innovation?; Why Is Innovation Important?; Warnings Regarding Innovation in Drug Discovery; Open Source Models; Nonprofit Models; Recommendations; References; 4: The Changing Face of Innovation in Drug Discovery; Introduction; Core Objectives of the Drug Discovery Process
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Major Innovations in Technology Have Advanced Drug DiscoveryAn Important Trend: Academic and Pharmaceutical Organizations Are Collaborating in Support of Drug Discovery; Future Perspectives: Where Is Innovation Leading?; References; 5: Current Trends in Collaborative Drug Discovery and Strategies to De-Risk Precompetitive Initiatives; Pharmaceutical Industry's Perspective; Academia's Perspective; Open (Collaborative) Innovation: A New Business Model; Drug Discovery through Collaborations; Drug Discovery through Consortia; Drug Discovery through Repurposing Strategies
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Probe Discovery in Public DomainEffective Management of Academia-Pharma Collaborations; Concluding Remarks; References; Notes; 6: A Perspective on the Evolution of Collaborative Drug Discovery and Future Challenges; Evolution of Collaborative Drug Discovery; Challenges for Collaborative Drug Discovery; Conclusion; References; Part II: Governmental Initiatives Accelerate Precompetitive Collaboration; 7: The Value of University-Industry Partnerships; Guiding Principles for University-Industry Collaborations; The Johnson Continuum; Role of Cocreation: Companies, Government, and Universities
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Funding for Collaborations with AcademiaNew Initiatives to Transform University-Industry Collaborations; Issues Affecting University-Industry Collaborations; Differences between Large- and Small-/Medium-Sized Companies; Large Companies Share Certain Characteristics; Small- and Medium-Sized Enterprises (SMEs) Offer a Contrasting Perspective; The National Academies' University-Industry Demonstration Partnership; Strategies for Building High-Value, High Return U-I Partnerships; Conclusion; Note on this Chapter; Note; References
526 ## - STUDY PROGRAM INFORMATION NOTE
Department General Management
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug Discovery.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Public-Private Sector Partnerships.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Pharmacology.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug development.
Source of heading or term fast
-- (OCoLC)fst00898670
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Public-private sector cooperation.
Source of heading or term fast
-- (OCoLC)fst01083445
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug Discovery.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Public-Private Sector Partnerships.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug development.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Public-private sector cooperation.
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Public-Private Sector Partnerships.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
655 #0 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chaguturu, Rathnam,
Relator term editor of compilation.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Print version:
Title Collaborative innovation in drug discovery
Place, publisher, and date of publication Hoboken, New Jersey : John Wiley & Sons Inc., [2014]
International Standard Book Number 9780470917374
Record control number (DLC) 2013035525
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Wiley series on technologies for the pharmaceutical industry.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://dx.doi.org/10.1002/9781118778166">http://dx.doi.org/10.1002/9781118778166</a>
Public note Wiley Online Library
994 ## -
-- 92
-- DG1

No items available.